[1]
“ Treatment of Philadelphia Chromosome-negative Myeloproliferative Neoplasms in 2024: A Concise Review”, Can Hematol Today, vol. 3, no. 3, pp. 19–31, Dec. 2024, doi: 10.58931/cht.2024.3357.